Matthew Porteus
Stanford University
H-index: 70
North America-United States
Top articles of Matthew Porteus
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Functional MRI to Evaluate Inhibition As a Feature of Executive Function in Patients with Sickle Cell Disease Post HSCT: A Pilot Study | Transplantation and Cellular Therapy | Heather Alva Lara Foland-Ross Tami John Matthew H Porteus Allan L Reiss | 2024/2/1 |
TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function | bioRxiv | Alexander J Dimitri Amy E Baxter Gregory M Chen Caitlin R Hopkins Geoffrey T Rouin | 2024 |
Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells | Developmental Cell | Jonas L Fowler Sherry Li Zheng Alana Nguyen Angela Chen Xiaochen Xiong | 2024/4/1 |
Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states | Molecular Biology of the Cell | Celeste Riepe Magda Wąchalska Kirandeep K Deol Anais K Amaya Matthew H Porteus | 2024/2/1 |
Epigenetic signature and key transcriptional regulators of human antigen-specific type 1 regulatory T cells | bioRxiv | Alma-Martina Cepika Laura Amaya Colin Waichler Mansi Narula Michelle M Mantilla | 2024 |
Nuclease-mediated genome editing of primary cells and related kits | 2022/1/27 | ||
Gene correction for scid-x1 in long-term hematopoietic stem cells | Nature communications | Mara Pavel-Dinu Volker Wiebking Beruh T Dejene Waracharee Srifa Sruthi Mantri | 2019/4/9 |
Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy | Hana Y Ghanim Matthew H Porteus | 2024/1/17 | |
Combining Cell-Intrinsic and-Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies | bioRxiv | William N Feist Sofia E Luna Kaya Ben-Efraim Maria V Filsinger Interrante Nelson A Amorin | 2024 |
Engineering inducible signaling receptors to enable erythropoietin-free erythropoiesis | bioRxiv | Aadit P Shah Kiran R Majeti Freja K Ekman Sridhar Selvaraj Eric Soupene | 2024 |
Investigating adverse genomic and regulatory changes caused by replacement of the full-length CFTR cDNA using Cas9 and AAV | Molecular Therapy-Nucleic Acids | Sriram Vaidyanathan Jenny L Kerschner Alekh Paranjapye Vrishti Sinha Brian Lin | 2024/2/2 |
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells | Nature Communications | Ron Baik M Kyle Cromer Steve E Glenn Christopher A Vakulskas Kay O Chmielewski | 2024/1/2 |
Genome editing of graft-derived T-cells for post-transplant immunotherapy | 2024/2/20 | ||
Genetically corrected RAG2-SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency | Blood Advances | Mara Pavel-Dinu Cameron L Gardner Yusuke Nakauchi Tomoki Kawai Ottavia M Delmonte | 2024/4/9 |
Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypes in R6/2 mice | bioRxiv | Danielle A Simmons Sridhar Selvaraj Tingshuo Chen Gloria Cao Talita Sauto Camelo | 2024 |
Enhanced Immune Reconstitution and Reduced GvHD Risk with T-allo10 Infusion Post Aβdepleted-HSCT in Pediatric and Young Adult Patients with Hematologic Malignancies | Transplantation and Cellular Therapy | Alice Bertaina Rosa Bacchetta David C Shyr Gopin Saini Jennifer Lee | 2024/2/1 |
A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5-and CXCR4-tropic HIV-1 infection | Cell stem cell | Amanda M Dudek William N Feist Elena J Sasu Sofia E Luna Kaya Ben-Efraim | 2024/4/4 |
Gene correction for x-cgd in hematopoietic stem and progenitor cells | 2023/11/9 | ||
Using Inducible Signaling Receptors to Increase Erythropoietic Output from Genome-Edited Hematopoietic Stem Cells | Blood | Kiran R Majeti Aadit P Shah Sofia E Luna Eric Soupene Simon N Chu | 2023/11/28 |
Crispr-based foxp3 gene engineered t cells and hematopoietic stem cell precursors to treat ipex syndrome patients | 2023/3/16 |
